[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100603945":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":10,"centralContacts":13,"locations":19,"responsibleParty":43,"collaborators":10,"id":45,"slug":46,"hasResults":47,"nctId":48,"briefTitle":49,"officialTitle":49,"acronym":50,"eligibilityCriteria":51,"healthyVolunteers":47,"sex":52,"minAge":53,"maxAge":54,"enrollmentInfo":55,"targetDuration":10,"studyType":58,"phases":10,"briefSummary":59,"conditions":60,"keywords":62,"overallStatus":22,"whyStopped":10,"lastUpdateSubmitDate":68,"lastUpdatePostDateStruct":69,"startDateStruct":72,"completionDateStruct":74,"leadSponsor":76,"locationsCount":77},{"fullName":5,"class":6},"AstraZeneca","INDUSTRY",[8,11],{"label":9,"type":10,"description":10,"interventionNames":10},"Non-Small Cell Lung Cancer (NSCLC)",null,{"label":12,"type":10,"description":10,"interventionNames":10},"Small Cell Lung Cancer (SCLC)",[14],{"name":15,"role":16,"phone":17,"phoneExt":10,"email":18},"AstraZeneca Clinical Study Information Center","CONTACT","1-877-240-9479","information.center@astrazeneca.com",[20,34],{"facility":21,"status":22,"city":23,"state":24,"zip":25,"country":26,"countryCode":27,"cosmosGeoPoint":28,"geoPoint":33,"contacts":10},"Research Site","RECRUITING","Calgary","Alberta","T2N1N4","Canada","CA",{"type":29,"coordinates":30},"Point",[31,32],-114.08529,51.05011,{"lat":32,"lon":31},{"facility":21,"status":22,"city":35,"state":36,"zip":37,"country":26,"countryCode":27,"cosmosGeoPoint":38,"geoPoint":42,"contacts":10},"Toronto","Ontario","M5T3M6",{"type":29,"coordinates":39},[40,41],-79.39864,43.70643,{"lat":41,"lon":40},{"type":44,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100603945","lung-roll-treatment-patterns-and-cost-of-illness-of-lung-cancer-in-canada-100603945",false,"NCT07143110","LUNG-ROLL: Treatment Patterns and Cost of Illness of Lung Cancer in Canada","LUNG-ROLL","Inclusion Criteria:\n\n* Patients with lung cancer between January 1, 2018 and end of the Selection Period.\n* Patient is 18 years of age or older on diagnosis date.\n* Patient has at least 12 months of health insurance coverage prior to the diagnosis date.\n\nExclusion Criteria:\n\n* Diagnosed with any other cancer in the 5-year period prior to January 1, 2018.\n* Diagnosed with any other cancer concurrently (i.e., on the same date) as lung cancer diagnosis.\n* Invalid or incomplete records for key variables (e.g., missing year of diagnosis, missing cancer type).\n* Non-Ontario or non-Alberta resident on diagnosis date.","ALL","18 Years","130 Years",{"count":56,"type":57},60000,"ESTIMATED","OBSERVATIONAL","LUNG-ROLL is a retrospective cohort study that will describe the contemporary treatment patterns, prevalence and incidence, patient demographic and clinical characteristics, clinical outcomes, and healthcare resource use\u002Fcosts for patients with lung cancer in Canada (specifically, Alberta and Ontario) using administrative data.",[61],"Lung Neoplasms",[61,63,64,65,66,67],"Non-Small-Cell Lung","Small Cell Lung","Epidemiology","Treatment Patterns","Real-World","2026-05-20",{"date":70,"type":71},"2026-05-22","ACTUAL",{"date":73,"type":71},"2025-08-20",{"date":75,"type":57},"2027-09-30",{"name":5,"class":6},2]